Literature DB >> 6810413

Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta.

T Hamazaki, A Hirai, T Terano, J Sajiki, S Kondo, T Fujita, Y Tamura, A Kumagai.   

Abstract

A highly purified ethyl ester of EPA (EPAEE) (74%) was manufactured from sardine oil. Sixty mg/kg/day of EPAEE was given orally to male Wistar rats for 8 weeks. No side effect or toxicity from the administration of EPAEE was observed. Plasma EPA concentration and the ratio of EPA to arachidonic acid were significantly increased, compared with control Wistar rats. An enhancement of PGI2-like substance production by aortas obtained from rats fed EPAEE was noted. Conversion of EPA to delta 17-6-keto-PGF1 alpha, a stable metabolite of PGI3, could not be detected by an incubation study of 14C-EPA and aortas either from rats fed EPAEE or from control rats. Therefore, PGI2-like substance produced by rat aorta is most likely to be PGI2 itself and not PGI3.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810413     DOI: 10.1016/0090-6980(82)90116-2

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  18 in total

1.  Enteral absorption in man of eicosapentaenoic acid in different chemical forms.

Authors:  S el Boustani; C Colette; L Monnier; B Descomps; A Crastes de Paulet; F Mendy
Journal:  Lipids       Date:  1987-10       Impact factor: 1.880

Review 2.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

3.  Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes.

Authors:  M Fujikawa; N Yamashita; K Yamazaki; E Sugiyama; H Suzuki; T Hamazaki
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Influence of a diet rich in eicosapentaenoic acid on the development of rat paw oedema and on the formation of prostaglandins I2 and E2.

Authors:  W Sametz; H Juan
Journal:  Agents Actions       Date:  1985-12

5.  Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester.

Authors:  T Hamazaki; E Takazakura; K Osawa; M Urakaze; S Yano
Journal:  Lipids       Date:  1990-09       Impact factor: 1.880

6.  Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes.

Authors:  C E Borgeson; L Pardini; R S Pardini; R C Reitz
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

7.  Effect of eicosapentaenoic acid ethyl ester on proteinuria of streptozotocin-induced diabetes mellitus in rats.

Authors:  M Fujikawa; K Yamazaki; S Sawazaki; H Taki; M Kaneda; M Urakaze; T Hamazaki; S Yano; T Fujita
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

8.  Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.

Authors:  A H Tashjian; E F Voelkel; D R Robinson; L Levine
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  The effect of linoleic, arachidonic and eicosapentaenoic acid supplementation on prostacyclin production in rats.

Authors:  N J Mann; G E Warrick; K O'Dea; H R Knapp; A J Sinclair
Journal:  Lipids       Date:  1994-03       Impact factor: 1.880

10.  Intravenous infusion of tridocosahexaenoyl-glycerol emulsion into rabbits. Effects on leukotriene B4/5 production and fatty acid composition of plasma and leukocytes.

Authors:  N Nakamura; T Hamazaki; K Yamazaki; H Taki; M Kobayashi; K Yazawa; F Ibuki
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.